TAM
BIOR

Tucker Asset Management’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History

Tucker Asset Management’s Portfolio BIOR Stock Details BIOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Hold
0
– -$1 – 1605
2024
Q3 		– Hold
0
– – – 1455
2024
Q2 		– Hold
0
– – – 1662
2024
Q1 		– Hold
0
– – – 1640
2023
Q4 		– Hold
0
– – – 1455
2023
Q3 		– Hold
0
– – – 1369
2023
Q2 		– Hold
0
– – – 1156
2023
Q1 		– Hold
0
– – – 1177
2022
Q3 		– Sell
-2
Closed -$350 – 917
2022
Q2 		$350 Buy
+2
New +$422 ﹤0.01% 600

Tucker Asset Management's BIOR Position: Q4 2024 in Review

Tucker Asset Management held its Biora Therapeutics, Inc. Common Stock (BIOR) position steady in Q4 2024 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1605.

Tucker Asset Management first reported a position in BIOR in Q2 2022 and has held it in 1 quarter since. The position peaked at $350 in Q2 2022. 0 funds tracked by Wall St. Rank hold BIOR as of Q4 2024.

  • Tucker Asset Management held 0 shares of Biora Therapeutics, Inc. Common Stock worth $0 as of Q4 2024.
  • Tucker Asset Management left its Biora Therapeutics, Inc. Common Stock share count unchanged in Q4 2024.
  • Biora Therapeutics, Inc. Common Stock made up ﹤0.01% of Tucker Asset Management's portfolio in Q4 2024, its #1605 holding.
  • Tucker Asset Management first reported a position in Biora Therapeutics, Inc. Common Stock in Q2 2022 and has held it in 1 quarter since.
  • Tucker Asset Management's Biora Therapeutics, Inc. Common Stock position peaked at $350 in Q2 2022.
  • 0 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q4 2024.

Based on Tucker Asset Management's 13F filing for Q4 2024, filed 12 Feb 2025.